Cargando…
Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
Labetalol is used for the therapy of hypertension in preeclampsia. Preeclampsia is characterized by high soluble endoglin (sEng) concentration in plasma and coincides with intrahepatic cholestasis during pregnancy (ICP), which threatens the fetus with the toxicity of cumulating bile acids (BA). Ther...
Autores principales: | Cristina Igreja Sá, Ivone, Tripska, Katarina, Alaei Faradonbeh, Fatemeh, Hroch, Milos, Lastuvkova, Hana, Schreiberova, Jolana, Kacerovsky, Marian, Pericacho, Miguel, Nachtigal, Petr, Micuda, Stanislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909014/ https://www.ncbi.nlm.nih.gov/pubmed/36778021 http://dx.doi.org/10.3389/fphar.2023.1116422 |
Ejemplares similares
-
Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver
por: Igreja Sá, Ivone Cristina, et al.
Publicado: (2020) -
Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis
por: Lastuvkova, Hana, et al.
Publicado: (2021) -
Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats
por: Alaei Faradonbeh, Fatemeh, et al.
Publicado: (2022) -
Iron overload reduces synthesis and elimination of bile acids in rat liver
por: Prasnicka, Alena, et al.
Publicado: (2019) -
Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts
por: Vitverova, Barbora, et al.
Publicado: (2020)